Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

Yurdaydin, Cihan; KESKİN, ONUR; KALKAN, ÇAĞDAŞ; KARAKAYA, MUHAMMED; Caliskan, Aysun; Kabaçam, Gökhan; Onder, F.; Karatayli, Senem; Karatayli, Ersin; Deda, Xheni; Bozkaya, Hakan; Bozdayi, A.; Idilman, Ramazan

doi:10.1093/infdis/jix656

Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

Copy For Citation

Yurdaydin C., KESKİN O., KALKAN Ç., KARAKAYA M. F., Caliskan A., Kabaçam G., ...More

JOURNAL OF INFECTIOUS DISEASES, vol.217, no.8, pp.1184-1192, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 217 Issue: 8
Publication Date: 2018
Doi Number: 10.1093/infdis/jix656
Journal Name: JOURNAL OF INFECTIOUS DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1184-1192
Hacettepe University Affiliated: No

Abstract

Background. Interferon is the only treatment option in chronic delta hepatitis (CDH). A CDH database (333 patients, 161 with interferon treatment history) was analyzed for effects of treatment duration on virologic response and clinical outcomes.